ResearcherNorth Carolina Central UniversityNo recent work listed

Wenjun Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5671-1344; OpenAlex author ID A5061599798. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2019: 1 paper

Papers 1

Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk. Co-author DOI 10.1111/cas.14017 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

James L. Abbruzzese · 1 shared paper, 2019 · strength 0.09
- Paper Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk. DOI 10.1111/cas.14017 ↗
Bensong Duan · 1 shared paper, 2019 · strength 0.09
- Paper Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk. DOI 10.1111/cas.14017 ↗
Qingyi Wei Wei · 1 shared paper, 2019 · strength 0.09
- Paper Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk. DOI 10.1111/cas.14017 ↗
Xuefeng Zhang · 1 shared paper, 2019 · strength 0.09
- Paper Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk. DOI 10.1111/cas.14017 ↗
Xinyuan Xu · 1 shared paper, 2019 · strength 0.09
- Paper Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk. DOI 10.1111/cas.14017 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.